Loading organizations...
§ Private Profile · Tampa, FL, USA
Biopharmaceutical company producing pure cannabinoids via biocatalysis.
Teewinot Life Sciences has raised $19.3M across 2 funding rounds.
Teewinot Life Sciences has raised $19.3M in total across 2 funding rounds.
Teewinot Life Sciences has raised $19.3M across 2 funding rounds. Most recently, it raised $12.3M Series B in May 2017.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 5, 2017 | $12.3M Series B | Marc Riiska | — | Announced |
| Mar 8, 2016 | $7M Series A | Tuatara Capital | — | Announced |
Teewinot Life Sciences has raised $19.3M in total across 2 funding rounds.
Teewinot Life Sciences's investors include Marc Riiska, Tuatara Capital.